mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-09 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-08 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-08 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-08 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-08 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-08 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-08 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |